The impact of COVID-19 on antipsychotic prescriptions for patients with schizophrenia in Australia

TY - JOUR

T1 - The impact of COVID-19 on antipsychotic prescriptions for patients with schizophrenia in Australia

N1 - Publisher Copyright: © The Royal Australian and New Zealand College of Psychiatrists 2021.

PY - 2022/6

Y1 - 2022/6

KW - COVID-19

KW - Pharmaceutical Benefits Scheme

KW - antipsychotic prescription volumes

KW - schizophrenia

UR - http://www.scopus.com/inward/record.url?scp=85110220450&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85110220450&partnerID=8YFLogxK

U2 - 10.1177/00048674211025716

DO - 10.1177/00048674211025716

M3 - Article

AN - SCOPUS:85110220450

SN - 0004-8674

VL - 56

SP - 642

EP - 647

JO - Australian and New Zealand Journal of Psychiatry

JF - Australian and New Zealand Journal of Psychiatry

IS - 6

ER -